AMA Urges Caution, Clinical Focus in Medicare Cardiac Imaging Reforms

The Australian Medical Association (AMA) supports the Department of Health, Disability and Ageing's (DoHDA) intention to ensure Medicare-funded cardiac imaging items align with contemporary clinical practice. The DoHDA aims to promote equitable access and reduce barriers to timely care through these reforms.

Concerns Over Administrative Burden

However, the AMA has expressed concerns regarding the practical impact of these changes. Complex item structures and prescriptive claiming requirements may hinder effective clinical practice and significantly increase administrative burden, particularly in regional, rural, and remote settings.

Endorsement of Phase 1 Measures

The AMA offers its full support for the Phase 1 measures. These include clarifying the stress echocardiogram caveat, removing rigid frequency restrictions for myocardial perfusion studies when clinically justified, and improving descriptor clarity to reduce administrative uncertainty.

Conditional Support for Phase 2 Objectives

While Phase 2 objectives are supported in principle by the AMA, this endorsement is contingent. It awaits careful implementation design and the establishment of crucial safeguards.

These safeguards are intended to preserve rural access and maintain safety and quality, especially concerning myocardial perfusion studies streamlining, general practitioner-requested computed tomography of the coronary arteries (CTCA), and CTCA credentialing requirements.

Clinical Advice as Primary Determinant

The AMA consistently advocates for clinical expertise to guide healthcare policy. Sound clinical advice should remain the primary determinant for service design and Medicare support, particularly when non-invasive imaging can reduce the need for more invasive pathways.